Which mechanism best describes agonist neuromuscular blockade?

Which mechanism best describes agonist neuromuscular blockade?

• A. Facilitating ACh release
• B. Blocking calcium channels
• C. Activating receptors and preventing transmission
• D. Enhancing muscle contraction

Answer: (C)

Agonist neuromuscular blockade is best described by activating receptors and preventing transmission. In this context, an agonist binds to nicotinic acetylcholine receptors at the neuromuscular junction. When there is an exaggerated or prolonged activation of these receptors by the agonist, it leads to desensitization of the receptors. This desensitization hinders the ability of acetylcholine to effectively bind and produce muscle contraction, thus blocking the transmission of nerve impulses to the muscle fibers. While facilitation of ACh release or enhancement of muscle contraction are related to the overall function of neuromuscular transmission, these are not consistent with the concept of agonist-induced blockade. Instead, they reflect mechanisms that would promote, rather than inhibit, muscle activity. Similarly, blocking calcium channels refers to a different pharmacological pathway that can affect muscle contraction, but it does not specifically pertain to the mechanism of agonist neuromuscular blockade itself.

Agonist neuromuscular blockade is best described by activating receptors and preventing transmission. In this context, an agonist binds to nicotinic acetylcholine receptors at the neuromuscular junction. When there is an exaggerated or prolonged activation of these receptors by the agonist, it leads to desensitization of the receptors. This desensitization hinders the ability of acetylcholine to effectively bind and produce muscle contraction, thus blocking the transmission of nerve impulses to the muscle fibers.

While facilitation of ACh release or enhancement of muscle contraction are related to the overall function of neuromuscular transmission, these are not consistent with the concept of agonist-induced blockade. Instead, they reflect mechanisms that would promote, rather than inhibit, muscle activity. Similarly, blocking calcium channels refers to a different pharmacological pathway that can affect muscle contraction, but it does not specifically pertain to the mechanism of agonist neuromuscular blockade itself.